Compass Therapeutics LLC — Form D/A

Compass Therapeutics LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2015-05-28. The offering totals $1.0M, of which $575K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Schuetz ThomasDirectorHanover, NH
Schuetz ThomasExecutive OfficerHanover, NH
CARL GORDONDirectorSAN DIEGO, CA
Stephen SquintoDirectorStamford, CT
Errik AndersonDirectorCambridge, MA
Errik AndersonExecutive OfficerCambridge, MA
Errik AndersonPromoterCambridge, MA
Steve TregayDirectorSan Carlos, CA
Ben AuspitzDirectorCambridge, MA
Philip FerneauDirectorHanover, NH
THOMAS J SCHUETZDirectorCAMBRIDGE, MA
THOMAS J SCHUETZExecutive OfficerCAMBRIDGE, MA
THOMAS J SCHUETZPromoterCAMBRIDGE, MA
STEVEN J SQUINTODirectorCAMBRIDGE, MA
CARL J GORDONDirectorCAMBRIDGE, MA
SARA J MANNLEExecutive OfficerCAMBRIDGE, MA
VERED J BISKER-LEIBExecutive OfficerCAMBRIDGE, MA
ERRIK J ANDERSONDirectorCAMBRIDGE, MA
ERRIK J ANDERSONPromoterCAMBRIDGE, MA
BEN J AUSPITZDirectorCAMBRIDGE, MA
BRUCE J STEELDirectorCAMBRIDGE, MA
JEB J LEDELLExecutive OfficerCAMBRIDGE, MA
DAMON J BANKSExecutive OfficerCAMBRIDGE, MA
WILL J EDENDirectorCAMBRIDGE, MA
PIOTR J BOBROWICZExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2018-07-16D/A$170.2M$110.2M
2018-01-08D$50.0M$21.8M
2016-09-21D/A$170.2M$46.0M
2015-07-01D$121.0M$16.0M
2014-06-13D$1.0M$475K

More